# FDA recall D-851-2013

> **Hospira, Inc.** · Class II · drug recall initiated 2013-05-20.

## Product

Ondansetron Injection, USP, 4mg/2mL, (2mg/ml), 2mL single-dose Fliptop Vial, Rx only, Sterile, NDC 0409-4755-03, Hospira, Inc, Lake Forest, IL 60045.

## Reason for recall

Presence of Particulate; lot being recalled as a precaution due to the discovery of 2 particles found in a lot which preceded the recalled lot

## Distribution

Nationwide

## Key facts

- **Recall number:** D-851-2013
- **Recalling firm:** Hospira, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-05-20
- **Report date:** 2013-08-14
- **Termination date:** 2014-10-28

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-851-2013

## Citation

> AI Analytics. FDA recall D-851-2013. Retrieved 2026-06-08 from https://api.ai-analytics.org/recall/D-851-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*